Company Monitoring Page for Nkarta-Therapeutics

latest headlines for company on cafepharma

Nkarta goes back to basics
EP Vantage
Tue, 06/27/23 - 10:07 am
Tags:
Nkarta Therapeutics, natural killer cell therapy, NKX101
With new data, Nkarta builds case for ‘natural killer’ cell therapy
BioPharma Dive
Mon, 12/5/22 - 10:45 am
Tags:
Nkarta Therapeutics, cancer, blood cancer, natural killer cell therapies, NKX019
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site
Fierce Pharma
Wed, 07/14/21 - 10:48 am
Tags:
Nkarta Therapeutics, natural killer cells, San Francisco
Can we freeze them? Yes we can, says Nkarta
EP Vantage
Mon, 02/15/21 - 10:26 am
Tags:
NK cells, natural killer cell therapy, Nkarta Therapeutics
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments
Xconomy
Mon, 07/13/20 - 11:33 pm
Tags:
biotech, IPOs, Nkarta Therapeutics, Poseida Therapeutics, Inventiva
Another four biotechs scratch out the first number and ask for more as IPO boom continues
Endpoints
Fri, 07/10/20 - 11:00 am
Tags:
IPOs, biotech, Relay Therapeutics, Nkarta Therapeutics, Poseida Therapeutics, Inventiva
Trying to turn 'natural killers' against cancer, Nkarta raises $114 million
Bizjournals
Thu, 09/5/19 - 10:10 am
Tags:
Nkarta Therapeutics, IPOs, cancer, natural killer cells, CAR-T

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.